MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0083984
Imhotef Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹99.4 Lakh
▲ 14% YoY
Net profit · FY 2025
₹1.71 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹10.74 Lakh
EBITDA margin 10.8%
Authorised capital
₹80 Lakh
Registered with MCA
Paid-up capital
₹76 Lakh
Issued & subscribed
Open charges
₹13 Lakh
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About Imhotef Pharmaceuticals Private Limited
Data last updated:
Imhotef Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U52310TN2014PTC096165. Its GSTIN is 33AADCI5613B1Z7 (Tamil Nadu).
The company has an authorised share capital of ₹80 Lakh and a paid-up capital of ₹76 Lakh. It is led by directors Rajaa Vimala and Raja G Gajendran.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹99.4 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.71 Lakh (net margin 1.7%) and EBITDA of ₹10.74 Lakh (EBITDA margin 10.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹13 Lakh on record.
Imhotef Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0083984). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website imhotef.com.
Company details
CIN U52310TN2014PTC096165
Registration Number 096165
Incorporation Date 13 June 2014
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0083984
Key People
Rajaa Vimala Director Raja G Gajendran Director Recognitions & Rankings of Imhotef Pharmaceuticals
Contact details
Imhotef Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is imhotef.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address#96 First Floor, East Facing Dr.Murthy Nagar Main Road, Chennai, Tamil Nadu, India – 600050
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Imhotef Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Imhotef Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Imhotef Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Imhotef Pharmaceuticals Private Limited, buy the company report.
Financials of Imhotef Pharmaceuticals Private Limited
FY 2024 filings availableImhotef Pharmaceuticals Private Limited reported revenue of ₹99.4 Lakh (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹99.4 Lakh ▲ 14%
Net profit · FY 2025
₹1.71 Lakh margin 1.7%
EBITDA · FY 2025
₹10.74 Lakh margin 10.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 9%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 304%
3 years · compounded
▲ 13%
5 years · compounded
▲ 30%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 14% growth in the latest year. EBITDA rose 304% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.8% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Imhotef Pharmaceuticals Private Limited, buy the company report.
Board of directors of Imhotef Pharmaceuticals Private Limited
Imhotef Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajaa Vimala | Director | 13 Jun 2014 | 12 Years 4 Months | Current |
| Raja G Gajendran | Director | 13 Jun 2014 | 12 Years 4 Months | Current |
Auditor
Imhotef Pharmaceuticals Private Limited is audited by S SENTHIL & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S SENTHIL & CO | FY 2022 | 013348S |
Shareholding
The shareholding of Imhotef Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Imhotef Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 May 2022 | 100597855 | Hdfc Bank Limited | ₹13 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Imhotef Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Imhotef Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Imhotef Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCI5613B1Z7 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Imhotef Pharmaceuticals Private Limited, buy the company report.
Recent activity
Imhotef Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Raja G Gajendran was appointed as Director on 13 Jun 2014.
AGM
Imhotef Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Imhotef Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.00 Lakh with Charge ID 100597855 was registered on 11 May 2022.
Appointed
Raja G Gajendran was appointed as Director.
Appointed
Rajaa Vimala was appointed as Director.
Incorporation
13 Jun 2014
Imhotef Pharmaceuticals Private Limited was registered on 13 Jun 2014 with Roc Chennai & aged 12 years 4 months as per MCA records.
Frequently asked questions
Imhotef Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 June 2014 (12+ years old) and is registered under CIN U52310TN2014PTC096165.
Imhotef Pharmaceuticals has 2 current directors:
- Rajaa Vimala - Director
- Raja G Gajendran - Director
The latest financial statements of Imhotef Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Imhotef Pharmaceuticals is 33AADCI5613B1Z7, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Imhotef Pharmaceuticals is U52310TN2014PTC096165. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Imhotef Pharmaceuticals was incorporated on 13 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chennai.
Raja G Gajendran was appointed as Director on 13 Jun 2014. Rajaa Vimala was appointed as Director on 13 Jun 2014.
Yes, Imhotef Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0083984).
Imhotef Pharmaceuticals can be reached through the website imhotef.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Imhotef Pharmaceuticals is at #96 First Floor, East Facing Dr.Murthy Nagar Main Road, Chennai, Tamil Nadu, India – 600050.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages